Comment on "Hypometabolic Gliomas on FET-PET-is There an Inverted U-curve for Survival?"

Overview

Journal Neuro Oncol

Publisher Oxford University Press

Specialties Neurology
Oncology

Date 2019 Sep 11

PMID 31504819

Citations 5

Authors

Norbert Galldiks

Antoine Verger

Timothee Zaragori

Marcus Unterrainer

Bogdana Suchorska

Philipp Lohmann

Jorg C Tonn

Karl-Josef Langen

Nathalie L Albert

Affiliations

Soon will be listed here.

Citing Articles

Autoradiography of Intracerebral Tumours in the Chick Embryo Model: A Feasibility Study Using Different PET Tracers.

Krause S, Florea A, Choi C, Worthoff W, Heinzel A, Fischer S Mol Imaging Biol. 2025; .

PMID: 39838234 DOI: 10.1007/s11307-025-01983-9.

Therapy Defining at Initial Diagnosis of Primary Brain Tumor-The Role of F-FET PET/CT and MRI.

Nagy D, Fedorcsak I, Bago A, Gati G, Martos J, Szabo P Biomedicines. 2023; 11(1).

PMID: 36672636 PMC: 9855996. DOI: 10.3390/biomedicines11010128.

Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.

Ninatti G, Sollini M, Bono B, Gozzi N, Fedorov D, Antunovic L Neuro Oncol. 2022; 24(9):1546-1556.

PMID: 35171292 PMC: 9435504. DOI: 10.1093/neuonc/noac040.

L-type amino acid transporter (LAT) 1 expression in F-FET-negative gliomas.

Vettermann F, Diekmann C, Weidner L, Unterrainer M, Suchorska B, Ruf V EJNMMI Res. 2021; 11(1):124.

PMID: 34905134 PMC: 8671595. DOI: 10.1186/s13550-021-00865-9.

F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors.

Mittlmeier L, Suchorska B, Ruf V, Holzgreve A, Brendel M, Herms J Cancers (Basel). 2021; 13(13).

PMID: 34202726 PMC: 8268019. DOI: 10.3390/cancers13133163.

References

Moulin-Romsee G, DHondt E, de Groot T, Goffin J, Sciot R, Mortelmans L . Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?. Eur J Nucl Med Mol Imaging. 2007; 34(12):2082-7. DOI: 10.1007/s00259-007-0557-4. View

Kamson D . Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?. Neuro Oncol. 2019; 21(10):1221-1222. PMC: 6784274. DOI: 10.1093/neuonc/noz122. View

Albert N, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim M . Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016; 18(9):1199-208. PMC: 4999003. DOI: 10.1093/neuonc/now058. View

Galldiks N, Unterrainer M, Judov N, Stoffels G, Rapp M, Lohmann P . Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients. Neuro Oncol. 2019; 21(10):1331-1338. PMC: 6784268. DOI: 10.1093/neuonc/noz083. View

Langen K, Galldiks N, Hattingen E, Shah N . Advances in neuro-oncology imaging. Nat Rev Neurol. 2017; 13(5):279-289. DOI: 10.1038/nrneurol.2017.44. View